The DOI matches its Crossref record.
Early Biomarkers of Stroke
Abstract
Background: The diagnosis and management of acute ischemic stroke are limited by the lack of rapid diagnostic assays for use in an emergency setting. Computed tomography (CT) scanning is used to diagnose hemorrhagic stroke but is relatively ineffective (<33% sensitive) in detecting ischemic stroke. The ability to correlate blood-borne protein biomarkers with stroke phenotypes would aid in the development of such rapid tests. Methods: ELISAs for >50 protein biomarkers were developed for use on a high-throughput robotic workstation. These assays were used to screen plasma samples from 214 healthy donors and 223 patients diagnosed with stroke, including 82 patients diagnosed with acute ischemic stroke. Marker assay values were first compared by univariate analysis, and then the top markers were subjected to multivariate analysis to derive a marker panel algorithm for the prediction of stroke. Results: The top markers from this analysis were S-100b (a marker of astrocytic activation), B-type neurotrophic growth factor, von Willebrand factor, matrix metalloproteinase-9, and monocyte chemotactic protein-1. In a panel algorithm in which three or more marker values above their respective cutoffs were scored as positive, these five markers provided a sensitivity of 92% at 93% specificity for ischemic stroke samples taken within 6 h from symptom onset. Conclusion: A marker panel approach to the diagnosis of stroke may provide a useful adjunct to CT scanning in the emergency setting.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Multiplexed protein measurement: technologies and applications of protein and antibody arrays
Kingsmore, S. F. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2006 · Cited by 715
Turner, R. J., & Sharp, F. R. (2016) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2016.00056 · Cited by 533
MMP-9 Inhibition: a Therapeutic Strategy in Ischemic Stroke
Chaturvedi, M., & Kaczmarek, L. (2014) · Molecular Neurobiology · doi:10.1007/s12035-013-8538-z · Cited by 296
Point-of-care immunotesting: Approaching the analytical performance of central laboratory methods
von Lode, P. (2005) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2005.03.008 · Cited by 290
Suzuki, S., Brown, C. M., Dela Cruz, C. D., Yang, E., Bridwell, D. A., & Wise, P. M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610394104 · Cited by 256
Metadata
- Authors
- Reynolds, M. A., Kirchick, H. J., Dahlen, J. R., Anderberg, J. M., McPherson, P. H., Nakamura, K. K., Laskowitz, D. T., Valkirs, G. E., & Buechler, K. F.
- Venue
- Clinical Chemistry
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-10-01
- Volume
- 49
- Issue
- 10
- Pages
- 1733-1739
- ISSN
- 0009-9147 (ISSN-L)
- 1530-8561
- OpenAlex
- W1991740017
- Cited by
- 235
- References
- 0
- FWCI
- 5.83
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Early Biomarkers of Stroke. https://app.cochat.ai/papers/10.1373/49.10.1733
- The paper
- Reynolds, M. A., Kirchick, H. J., Dahlen, J. R., Anderberg, J. M., McPherson, P. H., Nakamura, K. K., Laskowitz, D. T., Valkirs, G. E., & Buechler, K. F. (2003). Early Biomarkers of Stroke. Clinical Chemistry. https://doi.org/10.1373/49.10.1733
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.